Nordhealth AS: Granting of performance-based options to executive management and key employees
Helsinki, Finland, 30 September 2025: The board of Nordhealth AS (the "Company") has today approved the allocation of a maximum of 7,217,260 options linked to the Company's shares under an incentive scheme (the "Options") to members of the Company's executive management and key employees.
The Options vest based on a combination of time-based and share price-based performance. The time-based vesting is quarterly, over 4 years (1-year cliff). The performance-based vesting requires a minimum of 11% annual compounding growth in the share price from the start date (i.e. 10% or less annual growth means no options vest). The maximum Options vest if 25% or higher compounding share price growth has been achieved. There is a linear increase in vesting between 10% and 25%.
The vested Options may be exercised in designated exercise windows during a five year period subject to a possible extension of three additional years. The settlement of the Options may consist of shares on a one-for-one basis and/or cash at the discretion of the Company.
The following primary insiders and a close associate have been granted Options:
- Charles MacBain, CEO of the Company, was granted a maximum of 2,405,753 Options.
- Alexander Cram, CFO of the Company, was granted a maximum of 1,202,877 Options.
- A1KW B.V., a close associate of Karan Wallia, Therapy BU CEO, was granted a maximum of 2,405,753 Options.
Please refer to the attached notifications of trading for further details.
For further information, please contact:
Charles MacBain, CEO charles.macbain@nordhealth.com +44 75 3903 2200
Alexander Cram, CFO alexander.cram@nordhealth.com +32 470 69 30 20
This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12.
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 60,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with 400 employees working either remotely or from offices (collaboration hubs). Visit the company’s website at nordhealth.com.
